Skip to main content
See every side of every news story
Published • loading... • Updated

Health Canada approves Eli Lilly's GLP-1 pill for weight loss

The once-daily pill is approved for adults with obesity or related conditions and is also cleared to help treat Type 2 diabetes.

  • On Nov. 13, Health Canada authorized Eli Lilly's Foundayo, a daily GLP-1 pill for weight loss, offering patients an alternative to weekly injections.
  • Patients may prefer oral medication over injections; because Foundayo is a smaller molecule than semaglutide and tirzepatide, it can be absorbed orally without digestive breakdown.
  • Foundayo is approved for adults with obesity or those who are overweight with related medical problems, and it also helps treat Type 2 diabetes.
  • Eli Lilly expects the pills to reach pharmacies in January, while Vancouver endocrinologist Dr. Ehud Ur said it "seems to be just as good as if not better" for weight loss.
  • Competitor Novo Nordisk currently markets Rybelsus for Type 2 diabetes in Canada, though its Wegovy pill still awaits Health Canada approval.
Insights by Ground AI

8 Articles

The Toronto StarThe Toronto Star
+5 Reposted by 5 other sources
Lean Left

Health Canada approves Eli Lilly’s GLP-1 pill for weight loss

Health Canada has authorized a new GLP-1 medication for weight loss that is a pill taken every day, rather than weekly injections.

·Toronto, Canada
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 62% of the sources are Center
62% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Battlefords NOW broke the news on Wednesday, November 18, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal